• Inventors:
  • Assignees:
  • Publication Date: December 31, 1969
  • Publication Number:

Abstract

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (0)

    Publication numberPublication dateAssigneeTitle

NO-Patent Citations (0)

    Title

Cited By (94)

    Publication numberPublication dateAssigneeTitle
    US-2011071133-A1March 24, 2011Rigel Pharmaceuticals, Inc.Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors
    US-2007203162-A1August 30, 2007Rigel Pharmaceuticals, Inc.Compositions and methods for inhibition of the jak pathway
    US-8933080-B2January 13, 2015Rigel Pharmaceuticals, Inc.Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
    US-8501944-B2August 06, 2013Portola Pharmaceuticals, Inc.Inhibitors of protein kinases
    US-7576053-B2August 18, 2009Rigel Pharmaceuticals, Inc.Methods and compositions for treating degenerative bone disorders
    US-8138339-B2March 20, 2012Portola Pharmaceuticals, Inc.Inhibitors of protein kinases
    US-2010196511-A1August 05, 2010Rigel Pharmaceuticals, Inc.Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
    US-2006293311-A1December 28, 2006Rigel Pharmaceuticals, Inc.Compositions and methods for inhibition of the jak pathway
    US-7884119-B2February 08, 2011Rigel Pharmaceuticals, Inc.Triazole derivatives useful as Axl inhibitors
    US-8168636-B2May 01, 2012Rigel Pharmaceuticals, Inc.Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
    US-9156820-B2October 13, 2015Rigel Pharmaceuticals, Inc.Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
    WO-2007098507-A2August 30, 2007Rigel Pharmaceuticals, Inc.Compositions and methods for inhibition of the jak pathway
    US-9434732-B2September 06, 2016Genentech, Inc.Triazolopyridine JAK inhibitor compounds and methods
    WO-2009155565-A1December 23, 2009Genentech, Inc.Composés triazolopyridine inhibiteurs de jak kinase et procédés
    US-2007066670-A1March 22, 2007Basilea Pharmaceutica AgSubstituted benzimidazoles and their use for inducing apoptosis
    US-9868729-B2January 16, 2018Portola Pharmaceuticals, Inc.Inhibitors of protein kinases
    US-7385061-B2June 10, 2008Basilea Pharmaceutica AgFurazanobenzimidazoles
    US-9428464-B2August 30, 2016Chdi Foundation, Inc.Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
    US-9079898-B2July 14, 2015Rigel Pharmaceuticals, Inc.Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
    US-2011105511-A1May 05, 2011Rigel Pharmaceuticals, Inc.Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
    US-8546433-B2October 01, 2013Rigel Pharmaceuticals, Inc.Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
    US-9102625-B2August 11, 2015Portola Pharmaceuticals, Inc.Nicotinamides as JAK kinase modulators
    US-8609650-B2December 17, 2013Rigel Pharmaceuticals, Inc.Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors
    US-8952027-B2February 10, 2015Portola Pharmaceuticals, Inc.Inhibitors of syk and JAK protein kinases
    US-2009298823-A1December 03, 2009Portola Pharmaceuticals, Inc.Inhibitors of protein kinases
    US-9353126-B2May 31, 2016Rigel Pharmaceuticals, Inc.Substituted triazoles useful as Axl inhibitors
    US-8809347-B2August 19, 2014Rigel Pharmaceuticals, Inc.Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as AXL inhibitors
    US-8415365-B2April 09, 2013Rigel Pharmaceuticals, Inc.Compositions and methods for inhibition of the JAK pathway
    US-9206161-B2December 08, 2015Rigel Pharmaceuticals, Inc.Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors
    US-8618331-B2December 31, 2013Rigel Pharmaceuticals Inc.Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
    US-8809364-B2August 19, 2014Rigel Pharmaceuticals, Inc.Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
    US-7935693-B2May 03, 2011Rigel Pharmaceuticals, Inc.Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
    US-2011028503-A1February 03, 2011Rigel Pharmaceuticals, Inc.Compositions and methods for inhibition of the jak pathway
    US-2011105512-A1May 05, 2011Rigel Pharmaceuticals, Inc.Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
    US-9353124-B2May 31, 2016Rigel Pharmaceuticals, Inc.Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
    US-2009318407-A1December 24, 2009Portola Pharmaceuticals, Inc.Inhibitors of protein kinases
    US-7423157-B2September 09, 2008Basilea Pharmaceutica AgSubstituted benzimidazoles and their use for inducing apoptosis
    US-7872000-B2January 18, 2011Rigel Pharmaceuticals, Inc.Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors
    US-9359308-B2June 07, 2016Portola Pharmaceuticals, Inc.Pyrazine kinase inhibitors
    US-8431594-B2April 30, 2013Rigel Pharmaceuticals, Inc.Bridged bicyclic heteroaryl substituted triazoles useful as AXL inhibitors
    US-9593082-B2March 14, 2017Rigel Pharmaceuticals, Inc.Compositions and methods for inhibition of the JAK pathway
    US-8741898-B2June 03, 2014Rigel Pharmaceuticals, Inc.Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
    US-2011082131-A1April 07, 2011Rigel Pharmaceuticals, Inc.Triazole derivatives useful as axl inhibitors
    US-8735418-B2May 27, 2014Rigel Pharmaceuticals, Inc.Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases
    US-2008306099-A1December 11, 2008Rigel Pharmaceuticals, Inc.Compositions and methods for inhibition of the jak pathway
    EP-2975027-A1January 20, 2016Portola Pharmaceuticals, Inc.Nicotinamides as jak kinase modulators
    US-2008188455-A1August 07, 2008Rigel Pharmaceuticals, Inc.Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
    US-9624229-B2April 18, 2017Rigel Pharmaceuticals, Inc.Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases
    US-2007043061-A1February 22, 2007Basilea Pharmaceutica AgFurazanobenzimidazoles
    US-2007001033-A1January 04, 2007Magneti Marelli Powertrain S.P.A.Fuel injector
    WO-2012061428-A2May 10, 2012Portola Pharmaceuticals, Inc.Nicotinamides en tant que modulateurs des jak kinases
    US-8883785-B2November 11, 2014Chdi Foundation, Inc.Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
    US-9139581-B2September 22, 2015Portola Pharmaceuticals, Inc.Inhibitors of protein kinases
    US-9173882-B2November 03, 2015Rigel Pharmaceuticals, Inc.Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
    US-8906922-B2December 09, 2014Rigel Pharmaceuticals, Inc.Substituted triazoles useful as AXl inhibitors
    US-7709482-B2May 04, 2010Rigel Pharmaceuticals, Inc.Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
    US-2010184765-A1July 22, 2010Irm LlcProtein Kinase Inhibitors and Methods for Using Thereof
    US-8012965-B2September 06, 2011Rigel Pharmaceuticals, Inc.Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
    US-2010168416-A1July 01, 2010Rigel Pharmaceuticals, Inc.Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
    US-8962643-B2February 24, 2015Rigel Pharmaceuticals, Inc.Compositions and methods for inhibition of the JAK pathway
    US-2009111816-A1April 30, 2009Rigel Pharmaceuticals, Inc.Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
    US-7491732-B2February 17, 2009Rigel Pharmaceuticals, Inc.Compositions and methods for inhibition of the JAK pathway
    US-8399472-B2March 19, 2013Rigel Pharmaceuticals, Inc.Compositions and methods for inhibition of the JAK pathway
    WO-2009155551-A1December 23, 2009Genentech, Inc.Composés triazolopyridine inhibiteurs de jak kinase et procédés
    US-8258144-B2September 04, 2012Portola Pharmaceuticals, Inc.Inhibitors of protein kinases
    US-2008176847-A1July 24, 2008Rigel Pharmaceuticals, Inc.Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
    US-8658669-B2February 25, 2014Rigel Pharmaceuticals, Inc.Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors
    US-9676756-B2June 13, 2017Portola Pharmaceuticals, Inc.Substituted pyrimidinyl kinase inhibitors
    US-8796259-B2August 05, 2014Rigel Pharmaceuticals, Inc.N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as axl inhibitors
    US-9248190-B2February 02, 2016Rigel Pharmaceuticals, Inc.Compositions and methods for inhibition of the JAK pathway
    US-2008182862-A1July 31, 2008Rigel Pharmaceuticals, Inc.N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors
    US-7329652-B2February 12, 2008Vertex Pharamaceuticals IncorporatedDiaminotriazole compounds useful as protein kinase inhibitors
    US-8889673-B2November 18, 2014Genentech, Inc.Triazolopyridine JAK inhibitor compounds and methods
    US-8937070-B2January 20, 2015Portola Pharmaceuticals, Inc.Inhibitors of protein kinases
    US-2008188474-A1August 07, 2008Rigel Pharmaceuticals, Inc.Substituted triazoles useful as axl inhibitors
    US-9579320-B2February 28, 2017Portola Pharmaceuticals, Inc.Inhibitors of syk and JAK protein kinases
    US-RE42890-ENovember 01, 2011Basilea Pharmaceutica AgFurazanobenzimidazoles
    US-2007213375-A1September 13, 2007Rigel Pharmaceuticals, Inc.Triazole derivatives useful as Axl inhibitors
    US-8492373-B2July 23, 2013Rigel Pharmaceuticals, Inc.Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors
    US-8349838-B2January 08, 2013Rigel Pharmaceuticals, Inc.Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
    US-8309566-B2November 13, 2012Rigel Pharmaceuticals, Inc.Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases
    US-2011183986-A1July 28, 2011Rigel Pharmaceuticals, Inc.Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
    US-2013029988-A1January 31, 2013Celia Dominguez, Toledo-Sherman Leticia M, Dirk Winkler, Frederick Brookfield, De Aguiar Pena Paula CCertain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
    US-2008221089-A1September 11, 2008Rigel Pharmaceuticals, Inc.Compositions and methods for inhibition of the jak pathway
    US-2009041786-A1February 12, 2009Rigel Pharmaceuticals, Inc.Compositions and methods for inhibition of the jak pathway
    US-8815848-B2August 26, 2014Rigel Pharmaceuticals, Inc.Compositions and methods for inhibition of the JAK pathway
    US-8609687-B2December 17, 2013Genentech, Inc.Triazolopyridine JAK inhibitor compounds and methods
    US-8389557-B2March 05, 2013Rigel Pharmaceuticals, Inc.Triazole derivatives useful as Axl inhibitors
    US-2007203161-A1August 30, 2007Rigel Pharmaceuticals, Inc.Compositions and methods for inhibition of the jak pathway
    US-2006063756-A1March 23, 2006Francesco Salituro, Mark Ledeboer, Brian Ledford, Jian Wang, Albert Pierce, John Duffy, David MessersmithDiaminotriazole compounds useful as protein kinase inhibitors
    US-9650391-B2May 16, 2017Rigel Pharmaceuticals Inc.N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as Axl inhibitors
    US-9732073-B2August 15, 2017Rigel Pharmaceuticals, Inc.Compositions and methods for inhibition of the JAK pathway
    US-2011098274-A1April 28, 2011Rigel Pharmaceuticals, Inc.Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
    US-2009258864-A1October 15, 2009Rigel Pharmaceuticals, Inc.Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases